biotech · Plaque Psoriasis · Rheumatoid Arthritis · CANF
Can Fite Biopharma
Can-Fite BioPharma
Can Fite Biopharma clinical programs — 13 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 10 Bareket Street, פ"ת, IL, RAMAT GAN, L3, USA
- Employees
- 9
- Programs
- 20
- Drugs
- 4
- Patents
- 23
Can Fite Biopharma projects
13 ClinicalTrials.gov programs sponsored by Can Fite Biopharma.
Can Fite Biopharma has 13 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
CF 102
Can-Fite BioPharma
Chronic Hepatitis C
1 trial -
CF101
Can-Fite BioPharma
Ocular Hypertension
1 trial -
CF101
Can-Fite BioPharma
Osteoarthritis of the Knee
1 trial -
CF101
Can-Fite BioPharma
Rheumatoid Arthritis
3 trials -
CF101
Can-Fite BioPharma
Uveitis, Posterior
1 trial -
CF101 1mg
Can-Fite BioPharma
Plaque Psoriasis
1 trial -
CF102
Can-Fite BioPharma
Hepatocellular Carcinoma
2 trials -
CF102
Can-Fite BioPharma
Non-alcoholic Steatohepatitis (NASH)
1 trial -
Namodenoson
Can-Fite BioPharma
NASH - Nonalcoholic Steatohepatitis
1 trial -
Namodenoson 25mg
Can-Fite BioPharma
Pancreatic Adenocarcinoma
1 trial -
Namodenoson, Matching placebo for namodenoson
Can-Fite BioPharma
Non-Alcoholic Steatohepatitis (NASH) with F1-3 fibrosis
1 trial -
Piclidenoson
Can-Fite BioPharma
COVID-19
1 trial -
Piclidenoson
Can-Fite BioPharma
Lowe Syndrome
1 trial
Frequently asked questions
How many clinical projects does Can Fite Biopharma have?
13 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.